News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
 Content Sharing
INSILICO's UAE Team Nominates First AI-Enabled Preclinical Drug Candidate
INSILICO (03696.HK) announced that Insilico Medicine has officially nominated ISM0387, an MTA-cooperative PRMT5 inhibitor, as a pre-clinical candidate (PCC). Discovered locally by ...
Reset
Send
The window will close in 5 seconds
INSILICO's UAE Team Nominates First AI-Enabled Preclinical Drug Candidate
Close
Recommend
1
Positive
6
Negative
2
 
SHORT SELL
 
STOCK INFO
aacat by AASTOCKS
Open a new trading account to get 1 Intel/Selected Gold ETF share!

INSILICO (03696.HK)  -0.580 (-1.685%)    Short selling $38.36M; Ratio 18.304%   announced that Insilico Medicine has officially nominated ISM0387, an MTA-cooperative PRMT5 inhibitor, as a pre-clinical candidate (PCC).

Discovered locally by Insilico Medicine’s UAE team using the Company’s proprietary Pharma.AI platform, the program completed the early discovery workflow - from molecular design to optimization - in the UAE within less than 12 months, during which a series of hit compounds was generated within 30 days, followed by the completion of lead compound optimization within 6 months.
(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2026-06-12 16:25.)

Auto-translated by AI
View Original Text
This article was automatically translated by AI, the original language version should be considered the authoritative version. AASTOCKS.com Limited does not guarantee its accuracy or completeness and accepts no liability for any damages or losses arising from the use of this translation.

AASTOCKS Financial News
Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.